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From the Departmc7t1 of Pathology: Diili,sIQ" 0/ 
Tran$pllmtarion. ~ and IN tNP41'tmt)/1 a/Swgcry,t 
Presbytarian fgg1i~Dfff"ptlv Hospi/tU. l./7ril'fIT$,ly oj Pitrsbu"'8b. 
PIlIsDUrsb, P{f1ftb·yJvauia 
The morphologic ellclution oj hepatitiS B tJfnIs 
(HBY) liver tg{~enAK in 4$ ~patjc aJlograft nCipi. 
~ntA wbo ~ HIJV surface-antigen positi". (HBs. 
11&+ ) "I the time of livt!r replaCftntmt and tUbQ sur-
vived for mOTe tban 6() d"Y$ WAI studied Iry 7'out. 
bt.s(Qlogit; tmd 1m mtmOC)'tochtfmtcaJ atJalym o{ se-
rial palbology s/lKtmeiJS. The jimi.ing$ Dr t/HI. ,. 
lients wD"~ compared to til control group of 30 indio 
uUJlU!lls wbo were Immune co ebe HBY (antl-HBs 
anttboay POSilif!tf). out rt1qutred hepatic rep~fK 
m~n r /07' otber reasOnS. Eigbt of lbe /ony-jloe 
(18W,) HBsAg·positiue panems bllUe no m'Ologic 
IlvilJencf of !lBV y.tnfoction aft~ transplantation. 
A.II J 7 remainfng patie7r.1S an t'ft1zfectea; Z I (4 i16) 
tMvlJloped coronic activfI "fJ'ltilU and/or ciwbo-
sis, J (716) fkveJoped ~Ail/e rucrosu. /Ina 6 
( 14") det!tlop~d chronic tobula, bflpRlitis. On. 
pattent fost bv graft to cbronic refe<:Non, dwpile 
rrin/fI{;tio71 with the B uirtn. Foul' otbet' patitmts 
(9") dew/oped a cbronic cturier $lallJ. No long-
~ joUoUJ.u.p mopsies Wttrt1 fWllt(Qb/, in lbtl ,.,. 
ma1ntng rwo pauma. Tbe bistQlogiCft;Iturt$ M$O-
ct.tea Witb EgFDA/t4n~1on ~tt to ",U7'7"mt H.JJV 
In/eetton evoIved.!rOm an acute to cbronte pbfUe 
and wt!J"' sim.UQr to bepaltNs 8 sum (71 n07UZJlo. 
grll/led JiW'rS. Furthermore ,HsY-Tflatea lesloftS 
could be separa:ea./rOm rejecttO" unng rou"~ 
histology aionfl. The OTUy exception to lbts conel"-
$ion was th, ocCU'n"mce of a pecultar HBV-nr/Qted 
/lsfon in two recipilma. ruSCrlbfltlberft7L lmmuno-
bislOCbemi,at analym demons:rlUed rb, j1rf$fI7I" 
fJj utf'tJl IUUigml in "'moSt aU ~K ff~ In· 
flammation fZlso WQ.f commonty pre""t d-urmg 
HB Vatsetu. and. ~on:gistKd mosdy of accaM1ry ~I1fs 
and T lympbocyte$. Analysts of tIN e~cr of major 
histOCQmpalfbi/j1y compln rnatcbrng revealed PlO 
clear association betwem the number oj cLass I or 
11 "",*"b_ 01" m~rcbeC lmd tho- thvriopment, Or' 
[JrIUe-rn, olaai~ bt'patitis in Ibe aUograft. PIlC-uJiar 
patbologkalleJ'ations in~ ojrhebiopsies and 
jaU,a all<>gra/U after HBV reinftCfl'on suggesl$ 
tbat, under'specUU ctrcumstrmce$. the fl virus 7IU9' 
#:»C)'tOpalbtl:. (Am) PalboJ 1990, 137:667-676) 
The tational9 of uSlO9 fiver replaCement as therapy fot a 
disease such as hepatiti$ a Wus (HBV}induced dn'hosis. 
which predictably reCUl'S In a higI percentage of t>alients 
after transplantation. is debatable. 103 N&JeMelea some 
of the$O recipients wi! cleat the virus and others win 
evolve into ehtonic camera, with little Of no diGeaH acdv-
ity, and ttus benefit from liver ttanspiantatioo,H One can-
not question, however, the value of the intormelion ob-
tained from stlI:cM~ !t1e$e ptt)e..,ts :0 gain Insight into the 
palhobiologyof l'IepamJs a. 
Most known immune oIfectot mechanisms have, at 
some time. been :rr-pticared :n t-!BV·joC1uced liver damage 
beCauSe ttle vins Ir5eIt IS ItlCUght to be unable to directly 
injure hepatocyte$. UH' P!eSently the consensus opnon 
suggests !hat c.eIIUJar ItntrKJnJty is primarily responsible tor 
HBV·associated liver damago and humOfal immuMy pta--
tecta !he liver from hh:lctlon or ~fection when the VIlIS 
enters the biooo stream. !~~S An ur,s\Jt)stamiated c:coten· 
tIon suggests thai: CIBS$ I major histocompatibtlity com-
p1eJ( (MHC)·restrioted cytOroxic T lymphocytes (Clt) di. 
rected against the core IJltigen on !he hepatoey1a m~fg1D 
brane are thought to lyse the Wally infected celIS. Ii 
However MHC claSS • (OR) ;estricted genetahon of r· 
helper COlI fUnc:ion (via ~ eels) also appem to 
be ~[ beCauSe me ~nt of the final et!ee· 
tor pathways (CTI. and anlibOOe5) is dependeI'It on tIU 
rate-limiting Step.IO One ~ remember that the nt!lNly 
Surloocted by II1e ~ at ~ and PaI'IaIogy EducaIioc\ ~ 
~~K~of~~m"" 
~fotplAglicat1cnAprlleK1m 
AdCRsS NI)IIrIt ~ IQ A. J. CtmeIr!;, Qepwlrrw1r of~I 
~rtnity"""lafK~mA tSZ13-
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Table 1. Palbol()gic Jfani!2Slariotls Of ffepatllfs 8 Viml 
Lirl6r Dise(l$f! ami Dismburton ojNalilJt: !)iseases in 
the HBsr.b·posir/r.:e Cro"P 
Ois-'l! HBsAg+ H9$Ab"t' 
CAH with ClI'ttlOSI$ 34 24· 
Submassive 
nectasiS T 3 
CAH/cIn1\CISis aNi 
I1epalDma 4 2 
~dafv I;iiIiary 
cinhosis 0 
iotal ~ 90 
• M06t 011f1B&8 ;»tienm -. ~ad 10 /\aile I'IOIl-A. nQ1'16 CAli 
or Cl'fl)lOgeIIiC cirrllOSlS. 
placed Iivel' may be only partially MHC matcned QI' even 
be totally MHC incompatible. 
'1'h& follOlNing study had three goalS. l'he first wu to doc· 
ument Ihe pa1tdogic evoIutictt of HBV 0Isease atrer Iiv$:' 
replacement and identify histopalhologie features useful for 
the diagloois and management 01 f.!leSefecipients. The sec-
ond was to analyze the ~ mdings assoo-
ated wiltr recurrent H6v dsease in the ~1ogratt '!'he !1'lird 
goal was 10 study the elect of MHC rna!CtWlg or miSr'naIcho 
ing on 1t1e evdution of the disease after liver replaeament. 
Patients and Methods 
iwo groups of patients were selected for study. Th& first 
consisced of fD-~patie allogtaft reeiOients woo were sero-
logically HSsAg posllive at the tJ'ne of "ver transplantation 
and sucvived for mgre than 60 days after the operation 
(n .. 45). The second. or conltol group. consisted Of 30 
patients who were givetllMini because of non-8 acute or 
chronic liver oisease. but were irTU'I'U'\Q to the t-BJ (anti. 
HBs posilNe. HSsAbT). These patients alSO SUI'\IiIIeCi for 
at least 60 days after transplantation. The disttibuUon of 
It'Ie native ~ver diseases in both gElfIl~A is shown in Tabte 
,. All the patients recetved their pcirnery ailograits l)e. 
tween January t981 and .. hJ!y. 1968; follow-up ranged 
from 18 months 10 mote than 8 years. 
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Aft of the HBsAg-positive patients were treated with vari-
ous modaities in an atten"pt to Cleat \tie t-6V after liver re-
ptacement HepaIitis 8 mnune GIobuin (1'18¥3. Abbott lab-
oratories. Norih Chicago. i.). H3G plus HepatOV8X (H6Vx. 
Merck. Sharp & DotItne. W.t Poinl PA), 0( I'eCQrnbinant 
alpha interferon (IntrOn A. Schering Cotp. KenllwtXlh. NJ) 
were thO treaO'nenrs used. Three doses of HBIG (100 mil 
doee) were given intravenously, intraopetatively 0UIi'g the 
anhepa!ic phase. eItet canpletion of !he opetaU01. and 1 
rronlh \ate(. When possible the Uvee monthly spaced doSeS 
01 H6Vx were given before ~tafion or compIefed af-
ter the cperation in 1lO$e who requirled more mmediate liver 
~ent The alpha intecferon was admi'listered for 2 
weeks bam an::I for 6 weekS after tr.lnsplantaliotl. The 
I-BV seroIQ9ic proie fer both gOt.pS of patients is shOWn 
in Table 2. iw~ of the patients were seroIogieaIIypositNe 
tor anli-delta agent anoOodies. 
An paltlology specmens (Tatlie 3) were Obtained at 
the discretion of the clinical physicians and were fixed In 
neutral buffered formalin. ambedded in paratrin. sec· 
tioned at 4 IL. and :stained routinely wilh hematoxylin and 
eosin and trichrome. in ad<lition. aI me specim~s from 
the HBsAg-positive group and those from the control 
gro\lp with a 'hepatiric' hIStology were stained fCC' the 
presence of HBcAg and HBsAg with commerciaily 1lV811· 
able reegents (DAKO, Catpinteria, CA) lISng standard 
avidin-oiolin-complex methods (Vector. Burlingame. CAl. 
The faJled aJIOgrait ti,.,ecmens ~m tl'\C HBsAg·positiY1l 
group werw also stained fOt accessory cells (Mac 387. 
DAKO). i cells \L60. Secton-OlclCnscn; Mcuntai'lview, 
CAl. 8 cells (L26. QAKO). Interdigitating reticulum GeUs 
(S100 protetn. Oft.KO). beta-2-microglobuiin (DAKO). and 
IgM ru"d :gG (DA.KO). Approonate toona)in·fixed. paraffin· 
ombed<ied positive conlrolllSSue lor :he immunohisto-
chemIcal $tudies werIJ indUdec For T. B. Interdigitaling. 
and accessory ceus. tonsiUar tissue was used; forme hElP. 
abtis antigens. ~ pol)ilive liver tiSSue Wa,fi $taioed. 
ResUlt3 
Serology and Cfinical Course 
After Ttans"tantation 
9ritfty. ir. bt-BSAg-positivegrcup. eiglt of ttJo j)lIients had 
no serolOgic or !issue evIOenCe of !tie I-SII surface antigen 
geI<7e ItMS;lIantatlort AItet ~tation • 
S---:-::-CKIglc-..::_' _m_arket _______ lDfPsA9+KKK:KKK~K:KKt _~eB~sAbKK::KK:K+ __ .:...i-r'5sAg.:::.;:.+.;.;,:.:...;·'HSeAg+::.:.;:.:... __ e:KK::psA:=K::g~+:K:;lteeAg=:K;!KK-__ ~ 
HasAg-;.-.H6eAg+.t-EIeAb- 18 0 16 2 0 
HS&A9;.-. HgeAg+. H8eAO+ :3 0 3 0 0 
1'18sAg .... HeeAg-. t-eoAb+ 17 0 S 6 &t 
~K HBeI\g-.1"BeAtl- 7 0 4 1 2; 
HBsAg-. ebfsAb~ 0 30 30 
~ ~ = ~ 3 ~ 
• AlIA:II 18 moNh.oI follow ""., SUNIIIOI'i:. 
t AI 01 1ffa~D" patiena KKe~ IIOIIiIMt ILS ...... 
: Oespda ~~ 0' tnet-e.cAg. 0fVy ~prenb ~KII1eiUs pcUNe. 
DEC-19-97 FRI 05:42 PM TRANSPLANT SURGERY 
Table 3. Numbqr o.fPati'!1!1S and kumbernf~ (If 
PatboiolJ.j' Specimens Obtained After Transpiantarion 
Pillienw.and ~ eUsA~ HBsAb+ 
T oIaI patienls 45:90 
IJo.oef biOpSIeS l n 113 
ca~ aIogtatts 14 8 
~ 4 1 
A~ ob1ai'Ied after 
60 days 102 Si 
TOIaI patnology soecUnens 195 122 
and rernailed Mgative and diSease free Wffl a nlr11'num 
follow-up of at least 1.5 years. ~ lhese patients 
!'lave dearOO the virus. AI of tnem were H8eAg negative 
tlefln uanspantation and eix of the eight wert~ positive for 
riHSe.17 Six of me eight were treated with a COlTlbinaIixl 
of HBIG and H8Vx. one was given FN alone, and tne (fr 
mVting patiem was :,ot treated at all. Despte apparent 
. eteartng' 01 tne V1\;S ':ty sen.m &n1iget\ assays. only three 
con\eted to antj.H6S. ser~K" 
Four other patients, although stili terolo9iC31ly HBsAg 
positive after liver repiac:ernem. h8V1! been stable and ap-
pearea to have evll~d as chronic ,amers with mininal or 
no evidence of Iivel' enzyme efevaticns. In the remairing 
pallE!nts (n = 33), recurrent infection with serolOgic evi-
denee 01 disease activity ot ~ng $evecity was seen. 
Other tMtl tile aosence of the e rigen before trans:p!an. 
tation. no clinical or serologic parameter could predic1 
which patient would elBar me virus. In genera, the eftect 
of treatment modalities were cfrfflcult to evaluate. aHhough 
six of the eignt patients, whO apparently have cleared the 
V1nJS alter transplantation. were gIVen this regrnen. At the 
time 01 writing. 16 of 45 (33%) of the HesA9i'Ositive pa-
tients who SUrviVed for more 1han 00 days ~e died. 
Eleven died beCauSe ot mUl1iple-organ failure assoQated 
with recurrent HBV infectlal, wee to recurrent carei-
noma. all of whom haC! recurrent CArl and one from en 
inuacerebtal bleedfP Greater detail nto the cliJ\\oaI 
course, $erolOgy. and eftects ot the various treatment me-
daJitie, wil bo presQnted eISeWI'1ere. '7 
In \he HE3sAb-positive grouP. only six patients (20%) 
de~ any serologiC evidence of hepatic injufy. which 
hlSloiogically was diagnostie 0( COI'nI'atlble with a vi'a/ ati-
elegy. None of the HBsAb-positIve panerns bec8me tiB-
sAg positive aftet IranSplantatJon. CytomegalOlli'uS 
(CMV} waG ic:Ientif>ed as the cause 01 dysfunction in four 
and the two at,*,$ were preeumGd 10 have non-A.non-6 
hepatitis. 
Attl't4l tino of IUiling. 6 of tI'Ie JO (20%) t-esAbopositive 
patients died. SepsiS wtth mtltlPfe-organ failure (0 • 3) 
and (&CLmmt carcinoma (n - 3) were the majoI ceu$e5 
of lato dQath. '7 
Histopathologic Evolution of Disease 
HEssAg-posiliVe PSienrs 
For convenience of comparison. the postoperetive 
course wa; $apara1ed ir:to INee lime periOOs (0 to 60. 60 
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to 300. and more 1han 300 dayS) basetf on our prevjo~ 
experience with HBsAg-positiVe patients.3 Acute celluiai 
rejection and livet damage associated with Pl'eservaIion 
of the organ'l& were the most frequent diag10ses in the 
first 60 days, with ITlO$1 episodes of acute cellular rejec-
tion occurring n the fltSt 30 days. Acute hepatitis or acute 
with transition to chronicity was the most common dias-
n~ OtiItween &l and 300 cays. Thereafter a chronic car· 
rier state or CAH arrJ!or drlhOslS represented the disease 
manile:sl8tions associated with persistent intection of the 
aJlognrlt with H3V. !;sen oj these time periods Is dis· 
cussed in more detail below. 
Episodes at acUte oeIuIar rejection (ACR) were tlSto-
logic:aly documented in 25 of 45 (56%) pabQnts and all 
except two occurred within the first 30 days and were 
responsive to steroids andjor OKT3 tn¢ta.py. The hi$to. 
logic appearance was similar to that previously re-
portee. ~K1t In these specimen •• only mi'li'na! lOouiar eotiv· 
ity was seen and tissue stains for HBV antigens were ei· 
ther negative or showed focal cytoPlaSmic and/or ~ 
pogitivi1y {OI core anti!'.letl. althOugh SUttace antigen could 
be d9tected n tl'Ie sera of some of these patients. Two 
at the patient$ developed CMV hepa1iris after successful 
treetment of rejection. ~ of whom re5\XlI1ded to lOW-
ered rnmunosuppressiOl'l. 
OniV one patient de-..eIoped a late 0I'Iset of Am (81 
549 days). associated ....nth a reduction of immunosup-
pressive tttGrapy because 01 pregnancy: the diagnosis of 
ACR was made pathologically despite the presence of 
core antigen in almOSt ever'll18patOGyt6 nucleu$, as Oem-
onstrall!d by irnmunoperoxidase stainr1g (Figufe '). AJ. 
trough !his patient tranSIently responded to increased irn· 
fDtygno~ftpive therapy with a deCrease OJ portal in· 
flammaticn on biopsy and improvemern of serologi¢ 
parameters of liver injl.ry, she lost her graft 46 days later to 
chronic rejection. Examination pf the failed graft reveeled 
ftndings typical of chronic rejection with severe bile duct 
loss and obf~CfUtjoKoe arterIopatny EcD~e 1). Fewer ne:;)3-
tocyt8$ cmlained nuc:lear coro Gt'IligGn. and those tr.at 
were infected were fouod predominantly in the contrilObu-
lar regions. 
Ot.ring the 6(). to 3OO<Iay period and thereafter. the 
~ represemed i'1e morphologic consequences 
and evojutiCJl of persiStent HBV nfection of the aIlo9ratts. 
Early It the 6().lo 300-day time slot. the histOlOgiC findings 
~re typic::aJ of those reported for acute vir&! nepatilie in 
ncngrafteci livers. 1.1:_ me:e was Kupffet ~f hyportrt> 
pt,y and spotty acidoph/IIc necrOSiS 01 hepatocytes eo-
eanpanied by a mild lObUlar mononuclear infiltrate. Vary· 
ing deQrees of lobular disarray. hepatocyte baIooning, 
and a fnitd pori2II 8fId/O( 1000lar mononuclear infil1mc 
EcD~ 2) soon folbWGcl. Neither bile duct d&'nsge nor 
GUbendo1helial infiltration 01 portal c:x centtal veins, such 
as thai seen in ac:ute ceIIutar rejection, were prominent 
leat\ses. The cnIy apparent cli1fererce ~n these 
P. 04 
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FIgLn! 2. jll,. (lpical tlP/Harr;",cr: of 'Jelll" HBI,. ~tiDis WQS 
S"milRr 10 lbar :R:t:71 hi "olu~Dlograft /lI'C/'S amJ 1f11r<:""kf~fEf1"­
i:;~d by.:i Itl/JlllillII,i .. .:iY pvt:al ami/vr Ivbujar ;.!/ll:rall:, IOhI.· 
lar d~rragDK ami fx!pal~g"ff! ,."CYesis. klf~ 1M IIJdt "Iblill d .. cI 
Nn", .. A<·/ ...... ilU': I". fl(>nol IT,,( /. HfoE. Ori/:fllal m~ntjic:nlkD" 
X.1wl 
findings and thOse seen in nonaJlograft livers WIth acute 
hepatilis was a greater degree of Kupffer cell hypertrophy 
and less inflammation. During the latter stages o~ this lime 
period. changes of aCUte hepatitis ovettapPed witl'llhose 
pottendlng chronIC disease, which included a 9reat~ de-
gee 01 portal InlrammatlOn, portal-portal and porta/-ocn 
lrai brloglng. and piecemeal necrOSIS. 
No Change of rqlmunosuppreoD~ therapy was insti-
luted In mCS! of Inese patients al1er the diagnosIs 01 QCUte 
nepal!1.i£. except for the frst few patiern, who were re-
POrted on previouSly.3 In otherS. In wnom I'1Q change in 
therJ)py was institut~dIP a typical clinical course followed. 
The following It one example. P-<llient 1 presented 195 
~ys after tr8i'1Spiantation with AL T of 1627 (n! < 50 IU). 
AST 1667 (nl < 40 IU), and malaise. A biopsy diagnosis 
of acute HeY was made. No particular therapeutic inter· 
FAX NO. 412 624 6666 p, 06 
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vention was taken and 4 weeks later me levels 0: A!.-T 
and AST normalized. He again presented at 644 days with 
mildiy eIeva1ed transaminases, at whieh time a biopsy di-
agnosis of c1Yonie active hepatitis B was made, By 1293 
days the oa1ienl developed jaundice, enceph~opathyI 
and severe POrtal hypertension. He wa$ given a new liver. 
ihe failed alograft was cirrhotic, No obf~erative arteriopa· 
thy or significant duct lOSS were seen. Several other pa. 
tients, however, experienced progressive d"..terioration af. 
ter the ioitIaJ onsat of ~c dysfunction and eitner dleo 
1rom hepatic failure or had 10 be given new lJVetS (see 
below). 
Those patients whO survived for longer than 300 days 
wili1 the same a1klgraft demonstrated changes in later 
Rver biOpsies oi unresolVed or 'chronic' lObUlar Mpatitis, 
carner slate. or ongoirg CAH With progression toward cir-
chosis. The major featlres of those INith actiVe disease 
w~ro portallymphOhistJOeyt!c and Plasmacytic inflamma· 
tion with piecemeal neerosis (!=Igure 3). Again the 
changes wete Slmliar to tnose reponed tor nonaJlografled 
ilvers and no $ignifJCant bat. d~c:t oamage nor suoendo-
thelle! inlUtration was seon. 
There wer~ two cas •• however, that were similar to 
each other and diferent irom ~ reS! and from nonallo-
grahed ~ that merit speciai desoription because of 
tJ'IGir uniQue clinic course and histopathologic frncings. 
Clinically the firs! patient de\leloped mild ecute hePatitis 
al 271 days that spontaneously resolved. He remained 
itlteeted. Because of this, he was treated wrth FN, i:M 
again presented al 349 days wllh severe acute hepatitis, 
whch rapidly progressed to live.' failure and nepalic 
coma. requfing retr'an$plantation on the 378th day. The 
&eCOnd patient was wei a1\er liver replacement ~[il he 
presented at "5 days with n~eI vomiting. and ab-
daninal pain. A liver biopsy diagnosis of acute hepatitis 
WIth severe centrilobulat Dallooning was made. He rapidly 
ff~ 3. The· histologiC ~"Dlcr 0/ 0lI1 a/w ...... Sinri'-' 10 ., _ II't 1fOlUlOD(Jm/t JiVf<tt A:. /Yffdlr biOJ)$)' 1.5 g-~ ",:/trn' 
rl'AnspianUl'iol'. NoltJ IAv at: liM')' QJ riot: lirn;'ti"g ,fIia/t!. (bit /')rlligf"l pqnal j~ l1117d u,.r uK~ Qj' bH .. flu';' tiDrnag" (arrou: H&E. 
Of'illllal maR"'JcatlO1f x 120J. B: e~gw"Dplfle:"DDDD~DofA iUUSlMU"l lblI /HfI"iPO"CtJl atfitlll)', /7II4Q bilr duCt (til",,"'), .'lIi K~4lriM1t 
oj JlJlcA8/lI/·l'Ou·;;""ad.IP£Xjor IiflcA.g. Ot'igUltll/ magnljic;.liOrI )l.jOO). pl, guf~/IKDlrllt:i 
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F"lQure 4, Fatwd gf'Djt III' J T1/K~;Tf a palillJ'll who prvSl!1filfd witb subacute be(Mtic f/gigM~K A:. NOlI tClt plOmiJl/l7lt Dmlrai~entD"D 
(ft¥ pat1pg-~K1f11vl1 dl$Zrlhuuon qf tIIJOilm aTHI de.(enlr'lUin& bfKpa1rFCFlg1f~ plJU(;ity 0[ in/lsmll'Ultlon, Iilnd 'Ioaulrs of beulthJt ~~~ 
ill/i hEfp41aE;gt/~A (H-E. original magnijicahCrl X46). 6: Nmll iinr tbe C/ira{ af1llo4DfDf1fup~il" u18I'g<:/Y rcsrrir;ted I/(J 1M ""IF"-t11tlJ 
QeJXUOC),It:s, IIIbPf ixJlh "r~lfgffr "1Id '}rtap/asl"lfIC COnt "IDli~lff tHr. dfolIC"ed OffiX/or f1/k;A& Origin," magTltji~filtitm x 120). The 
ill5l!l (IPEXjOT H8CAg. origiMi mllgntjr;alion X.f80) show IIw ~ tinrltll'Cl:llio71 .?elWflr71 ~ i7l!IlCCI .. >tJ degfmt;7Y:Itin8 t;r:I/s and 
tro .. inft:t::u:tiI mnfD~ flltaJll;Iy-aPfWtZri7zg nne$. p, portat: C. 'Itl1tn1l. 
progressed to &ver failure In the next 16 days. neeessilat-
il'lQ retranSOlantation. Unfortunately bOtrl patients died 
withit'! ~ week at retransplantation from multiple·organ fill· 
ure and sepsis. Examinalion of bOth tailed primaIy allo· 
grafts revealed marked centrUobular hej)alOCyte baloon-
'"9 ana cholastQS;s WIth cer'.traI-centl2l and cantral-por· 
tal Qrchitectural cotlapse (F9Jre 4). There was unty a 
3canr focal mooonudeat p(rtal infiltrate and few. if aJTIj, 
lymphocytes wa-e Pfe$e."lt in tho distribuOOn of in~ed he-
patccytes. it was as if tM virus itself was responsible for 
the hepatocellular degeneration. Neither of these patients 
were pos:tive for :~ ~ Ilgent. InlorelStingly both wtere 
completely mismatched at ail A. 8. and DR MHC loci (see 
Elfect of MHC Matcrmg). 
In ~tilnK !here was one Olher patient whO experi-
enceo fulminant hepatic failure in ~ consecutive aDo-
grafts. After the first transplant. he pre.ented at 223 day. 
with ievere acute hepatitis. Immunosuppressive d'leraoy 
was 100000ered and Ihe liver faied 19 days later. at which 
time it was repiaced. The pe.tient again db well initially but 
beCame il only 00 days after pJacement of the second 
grail pev~ acute hepatitis. hiSlO/ogically inOl$li1guish· 
able irom IN! seen in Ihe first graft was cocumeotec en 
biopsy. He aied 15 days latet becaJse of hepatic and 
SUb$e(l\Jent multiple-ol'gan ~aureK The histology at initial 
presenlalion in both grWU was characteriZed bY a 0tISk 
lobular inftammatory response, disarray, and hepatocyte 
necrosiS typioal of Chat seen with severe acute hepaOOs. 
All thtee of these patients (two aboVe and this one) had 
ChfOnic: active disease With cirmOSiS r. Ihelr relive livers. 
FtneRy Ulere were eight patients who apparenUy had 
~ed tho I-!SV 4iter liver replacement Mininal pathO-
logic changes Wele seen in six. one had ongong Iym· 
pIlOCytio bile duct in!uIY. and the last palienr had 101'1-
grade ctYonic: active hepatitis and was seroIogicalIv poSi· 
~n for antibodias ':0 the hepatitis C vrulli. A summary of 
the evolution of the HBV diseaSe is ShOwn in Figure 5. 
Delta agent eoinfectiOn did not ~y alter .t:o 
course of HBV Wer oiSease attar transplantallon. Of :ne 
12 PQtienl$ who were positive. 4 deared the H8v. 7 devel· 
oped CAl-!. ~ of whom has apparenny cleared the ViruS 
a~ hIS third crene~entK and 1 developgd chronic lobular 
hepatitis. 
Sellen patients we:e given new tiver$ after their fitSt 
gtatts Sl£CU(IlOed 10 hepa~ 8. illro$ ded WIih" 2 weekS 
of tetransplantation because of multipl~rgan fsi/u(9. Inter· 
estingly'the second gra."'ts !~ ~Die tour Q!tIers again CleVE!!-
oped se.tete HBV liver diseaso. cOOfirmed'Ol bKJPS'/. ~y .. t 
~ !/most exaotty one half ti":e tirr.e ~~ tot !he first 
graft One of these latter patients dewioped chlOoic hepa-
titis. dumg wJich he apparenuy Cleared tIle \Iir\I$ (:ser0l0gi-
~ and immJoohistochelTdcaly) an~ evenrualy lost the 
graft :0 cnronio rejection. He tema.i'ls ftee ot Iha 8 viru$ 3 
i'Tla'I1I'lS after placement of hi$ IhiId liver_ 
:-IBsAb-pasitivfJ Palielln 
The histologic findings in this gOup of patients was 
srnilat :0 t.ho6$ seen in the H3sAg-positiVe group during 
I 
1 
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H8sAg'1' HBsAb+ 
-Cwse of graft faiure N &.r\Mldays N $JMva1 Clays 
Submas$ive/massive neClosi:!' 3 131·378 0 
Ctnlnic:: actiYe tlepatitiSprho$iS 4 203-2074 0 
CtYonC rejeCIlon 2 25S-632 .j 72-1021 
Hl!plltic anery iMmlbosis .& ~-P 2 2-358 
PrimaIy 00I"Ifur.::1ia'mg 1 18 2 1-28 
• These tnree Cl8IiGn\s IUt 1rom \tV! group 01 live graM that Iaied becaUse 01 tt.tnnam hez)arc: foLore seoorldaIy 10 ~ rII!aCSIS. 
1 T1v .. Of 1'-\If'oI11S were fI\'lfTI tne same patient:. 
t~e first eo days. Aet.l1e ceJlular rejeCtion .....as hiS101ogiCal1y 
verified in 20 of lI1e 3) patients (67%). all of whOm re-
sponded to ant/rejectlon 1herapy. Four of tM patien1$ de· 
veloped CMV hepatitis after treatment 01 rejection. which 
resotved WIth (empocary lowering of the immunosuppres-
sive regimen. 
Thereafter (2ner 60 days) tl1e histolOgic findinSS and 
diagnoses diflered dramaticaHy from those Of patients in· 
footed with t!'IQ 8 VlrlS The predominant findngs In fol-
low-up biopsies in this group were nonsoeciflc changes 
(n ,,. 13) or dlroroie portal inflammation wttI1 or ~thout 
ongoing b~e duct damage (1'1 = 10) and IlttIe or ~ ~ 
dence of piecemeal necrosis. consistent with an ongoi:lg 
rejection reaction or chroniC persiS1ent Ilepatilis. Four of 
Ine grafts were eventuaJy lest to ohrOOIC cejeCtio:-:. T\A.IO 
HBsAb-positive patienlS, however, had biopsies in this 
time periOd. Wlllcn were simiilU to thoee seen in tM e~ 
Ag-OOSitive got-p. but no H9V antigens were detected 
serologically or immunohistochemicaJly, 80th were diag-
nosed as hepatitis pathologically. One lOst his g!'81t at 1 50 
days from chronic rejecliOn and the other is st~ behg fol-
lowed. The r.rtlainins M patients have shown little 01' no 
evidence of aUograft dySfunction and no long-term follow-
up biopsje~ were available. 
Failed Allografts 
There was a total of 22 failed gafts removed at the time 
of retransplantation ftom the two groups: 14 from the 
HBsAg-po$iIiv9 and eght from the t-BsAb+ patient&. The 
causes ot graft taaure ate $hOwo i'I Table 4_ Pathologically 
it was not cfffi~ to dif[erentiale between the various etiol-
ogies. NOnimmunologic causes Of graft failure were sm-
ilM between the twogrcups.l-/owever craft lOSS from hep-
atitis arw:J/or cirrhoSiG wa; ;een only in HBsAg-pooItive pa-
tient$. None 01 the gra1ts rern~ from the t-esAb+ 
group_ or becaUM of chtOnie rejection from either group 
of patieol$. was cirrnotic. 
Immunopathologic Studies 
All but ()t\Q ot the '.J1 pat~nlp in whOm the HBsAg reap. 
peared in the serum after ~plantation had tissue de-
posits as well. The first evidMce of HBV ant~ns in the 
allografts was tht pteSeI'ICG of H8c.Ag in the cytoplasm 
and/or nucleus within 3 weeks after transplantation in one 
ease. During episode~ of acute hepatiti$, HSV antigens 
were usually detected in the allografts.''I There was a 
gradua! inaease in the numDei of po$itive cases and by 
250 to 300 days all but one of the patients Who were HBs-
Ag-pos~i ... e ana Who hac a late biopsy after transpIanta. 
tion had tissue deposits of HBV antigens, 10 
After reiniBCtion. there was a graaual Increase in -the 
percentage of hepatocytes containing HBcAg. both 
nudear and cytopla$mic, paJ1iClJ3l'ly during the evolutJon 
of acute 10 chronic eise&se. Nearly ali patients v.fio deve!' 
oped eAH contin.ted te exprt'$$ cylopIasrnic H8eAg. 
Among the cl'Irooic carriers (n - 4; 9'10), generalized cy-
toplasmic H8sAg was seen in one, wtjIe 1he three others 
$hewed goneraJized nuclear core antigen and fewer eels 
with cytoplasmic HBsAg.1' In t~ patients with progr~s· 
srve disease. e gadual declease In HBcAgt- cellS and an 
inctease in the HBsAg.positive ones was lOO'1d. 
One 01 the ttJo peculiar cases mentioned previou~y 
demonstrated panlobular exptession of HBcAg+ at 271 
days and at the time 01 graft faillXe (378 dayS) nUClear 
anCI cytOPlasmic core antigen staining Wi$ ijmited to the 
degeneraUng centril~ hepatocyte, (Figure 01). Mae 
healthy appearing Clusters of hepatocytes were generally 
Iocat&d in ZMe 1 of the acinus and only some eels con-
tained nuclear HBcAg. 
In the fafted allografts with CAH/c/rThosis, inflatrrnatory 
cellS in the portal tracts and lobUles contained a predomi-
nance of T cells (l,60+), although appreciable Clum~s 
011gG- and ~iog plasma cells were present in 
the portal spaces in some cases as well. A conspicuous 
finding was trle large nJmber of Irregular- and oendritic-
shaped ~ allIs (Mac 387 +) present in me tnclds, 
especially at the edge 01 the fimiting pates In areas of 
plecerrwl necrosis (F.gure 6). These ceJs also were eon· 
spiCuous in the lobl.lles in areas oj ;actiVe l)epatoci,e ne-
crOSIS, Oespile the largo number of Mac 387 +- celIS. theJO 
were only a tew S100+ celIS in the triads and these were 
located In the cenla- of the 1l'iads. 
Beta-O-mi:r~1in expression was diffieU: to intQl'_ 
pret but appearea to be present en the MpatocytO !:l,IT. 
p, DB 
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face membrane in a pan/obu/er distribution in grafts that 
faileo from acute hepatiti&, whereas in those with CAH 
and/or cirTllQS1S. ,Ile slaln~ was genetally re$tricted to 
ttle edge 01 the lobUleS/nodules in alee, of ongoing 
piecemeal necroSis. Bile ducts and endOthelia generally 
were positive. 
Effect of MHC Mismatching on HBV Disease 
Complete dOrlo( and recipient MHC profiles were avail-
ilbk! for 35 graf'.s. and in tM~e others the class I anllgens 
wete typed but t:"le DR antigens could not be classffied. 
11le effect of mismatching at 11'19 vanouSi MHC loci on graft 
SUl\llvaJ is shown in Table 5. ,\1ost of the patients were 
mismatched at one or more class I and II MHC loci be· 
cause no attempt was made I¢ prospectively match the 
livetS and recipients. No particulat effect was noted for 
class I matChing or mismalChing other than two peculiar 
cases. previoust'/ cescribeO. 'Nt'Io were completely mis-
matched at all A. a. and DR Iocllt Sl'.oud be noted. how-
ever. that there 'Hete folS other pallents wllO were m~D 
matched at all six loci. three of whom have dErJeIOped 
CAH and/or cirrhosis. ano one has chrooic loblJar hepati· 
tis on last biopi'(. There were only two patients c0m-
pletely matched at the DR lOCus: one evoNed into a 
Table 5. I1fftlct C,f .... ,HC .l1is1H4lcbinR (lrr Allograft S""fttJ4l 
CIVoIllc carrier and the o\her had low-grade chronic lobu-
lar ~s at last tollOw-uo. 6y COnlraSl. there was one 
patient who became a cnronic carrier who was mi$-
mateK~ at both DR loci. Overall there t~ no statistically 
signifiearu assoeiation between the degree 01 matching 
or mismatching ;],t dass I or n MHC antigens ano t11e oc· 
currence of what appeared to be acute or Chronic hepall-
tIa in the e1lOgtaft 
Discussion 
The 1Irst goal of ltIis study was to docunent tI'Ie ovolution 
of HeV Uver diQQaSG after nepatic replll.CP.fl'lenl. The re-
SIJlt& 8fe be$( summal'i7.ed in Figure 5. As might be ex· 
pected. recurrent infection 01 the aIIograf1 occurred in 37 
of 45 patients C82%): In Z4 palienn; (53%). reintection teo 
suited in seriOlJS disease in the form 01 chronIC active he,,· 
atllis (n .. 21; 47'fo) or submassive l'ISCI'osls (n = 3; 7%). 
The rernsin;,g patients had a histology at the laSt fellow-
up that OO\.id bel c!assK~ as chtorUc lobU.9r' hepatttls (n 
- 13; ,A.%) Of chronic carrier state (n = 4: 9%): t/'le long. 
term outlook for these patientS has yet to be determined. 
No Iong-tetm pAb'IoIogic follow-up was available in two 
patients. who era stil aJNe 942 and 999 days aftet trans· 
plant. 
Moe mismatcNs 
-----------------
MHC 
LOO 
A 
e 
DR 
2(1:221)/1 (Zl9) 
0(-)/0(-) 
o (-)/2 (198) 
5 (2")/11 (819) 
4~f1EeasF 
5 {4S2)f7 (8n) 
2 
0(8:)0)1'0 mO) 
9 (58$)/15 (697) 
T (522){11 (SOZ) 
Numbr!nt rfIhrt 10 runt>ct 01. f3iIecI ora~ grall:5 ";111 IUrDn n ~ fden~~ '-' 11U1\11Y111iI'ne$ In ~ Ody one graft Nt 
'-Iion/lOft'/1BV ..... IOCI __ ~irllhe~ 
.. 
.. 
... 
.. 
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The pathologic 1eatures ot liver injury associated with 
reclJrren: HBV in1ectlon in the allograft were not signifi. 
cantly dilterent 1rom those seen with hepatItIS e in non· 
grafted IjvQrs. Furthetmete biopsies from infeeted pa. 
tients demonstrated both acute and chrQt'lic phases. Con-
tinuing periportal hepatClCy1e necrosis in 1M chronic 
~se eventually progressed to cirrhosis in e number of 
patients dunng the SUJdy period. 
For the most part. niStoLoglc changes assoCIated with 
HBV·related dyslunetion were disti1\9UiShable from acute 
:u'ld Ohtonic rejection. The K&y feature used to make the 
~alU1ion was the focus of the inflammatory CQ!I dam-
age. In aC\Jle and Chronic rejeetion, the bile duelS were 
tho main targets oj lymphocytic injury. Venular injury 
could be seen in acute rejection as wall. In hepatltis. the 
hepalocYles were pre1erentially targeted for damage. 
Durn!;) acute dISease. the injury was pa.nlobUar in c:J5tribu-
{Ion. Whereas in tna cnronic aClive phase II was directed 
pnm3nly 8t peripo:1al hepa1ocytes. The only caveat was 
the presence of low.graoe lobular 'hepatilic' dlanges In 
several patients during th~ development 01 Chronic rajec-
lien in bOth the HBsAg-positive and HBsAb-positive 
groups. which led lO a misiaken diagnosis of hepatitis In 
one of the HBsAb-positive patients. One must be aler' .. 
\o'leCe1ore. to me pr~ence anc seventy of bile duct dam-
age in all cases. When present. a componerrt of rejection 
IS likely 10 be invOlved. Therebe rejection can be d:ag-
nosed wen in the presence of H3V in1ection 01 the all0-
graft. Tris poirrt fs exemplffied in the patient WhO lost her 
graff from rejection. even though the graft was iotecled. 
Immunopathologic studies demQllStrated that H8V an-
tigens are almost Invariabiy detected h the tiver d\Xlng 
diseaSe related 10 recurrent HeY infection. Exp'e35100 of 
core antigen was common duting the acute stage and 
persistem cytoplasmic core antigen eJq:re:rssion in the 
chronle phase generaly correlated with onooll'rJ disease 
activity.19 Hepatic inflammation also was frequently. but 
not Invariably. seen in the allografts during episodes of 
oysfurv::lion rolated to r&cvnGl"lI HSV intection. Jmmuno-
PhenotypiC ana~/sis has shown thaI most 01 the inflam. 
matory cells wetA T JyfTlJ:lhocytes and e¢oesaory oells In 
biopsies with HBV-associated dysfunction- Compared to 
Ine graftS Ina! fal,ed beCause of chroni:: rejection, peripor-
tal aCGeSGory cells were mor~ common and the T cxsIl$ 
were dislrtMed differently (see above). The observatioos 
strongly suggest tnar rnmunologic responses in 1I1e two 
disotde:-s at€ different. 
Static morphologi: studies. however. give Uttle or no 
information abOut tile fl.netiOnaI specificity of the inmll8t· 
~ cells. WMri'ler they am drec1ed at viral. altered he~ 
tocellular. or ioreign MHC antigens cr are merely secondo 
aty 10 the di;Qa5Q i~ unknown. Despite the lack of Iympho-
oyte functional studies. the acx;eletated hepatic damage 
associated v..1th rGinfoction of second aBogafts SL.ggeStS 
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that there may be an rnmunologic memory response or 
enhanced HBV virUence in this crClITIstance. 
We also noted that MHC dass I antigens are upregu-
laled on hepalocytes in areas 01 ongoing injlSy a$SOCt-
ated with H6V ln1ec11c;n. as <1etected by the presence of 
beta-2 microglobulin. One must remember. however. that 
these MHC antigens are thoSe Of 1!"1e OOn(y', end not the 
recipient effector cellS. 
Excapt for the two pac:uliar eases previously de-
&Orbed. we were unable to detect a sigrDFjf~t eon'C!iation 
bttween 1he degree of donor {recipIent I'IAHC matching or 
mismatching and the pattem or occurrence of what histo-
logically appeared to be hepatitis. AI1hough the na.mber 
of patients in this study was relatively small. the {.,dings 
suggestlhat Immune mechanisms other than, Qr in addi-
tion to. MHC·reStrlcted en. could be r~ible tor the 
hepatic nj~ associated with H8V infection of allografts. 
S1nkll'lg hepatocyte CytOlogiC degenerative chal199S as-
sociated with marked viral antigen expresSion and little. n 
any. nflammation was £een. Under These speciai ('jrcum-
stances. th~ virus itself may be cytopathic. Wnether the 
ob$er\lalions reported tweln can be incorporated into a 
hypothesis regarding liver damag. associated with HB'v 
,lfection in the general population is open to speculation. 
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